Faculty of medicine - Assiut university
Asyut, Egypt
NCT Number: NCT03853005
High volume hemodiafiltration (HVHDF) has been used in septic patients to get hemodynamic improvement and possibly survival benefit.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Asyut, Egypt
Sepsis, defined as life-threatening organ dysfunction caused by dysregulated immune response to infection. Hemofiltration has been suggested as beneficial in restoring immune homeostasis. High volume hemodiafiltration (HVHDF) is a hybrid method of intermittent renal replacement therapy (RRT), where high filtration volumes are applied. In several studies; higher filtration volumes have been shown to achieve hemodynamic improvement and possibly survival benefit in patients with septic shock.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Organ dysfunctions are defined as following:
Respiratory dysfunction (criteria for ARDS):
CNS failure:
CVS dysfunction:
Liver dysfunction:
Renal dysfunction:
Bone marrow depression:
Exclusion criteria
Patients will receive HVHDF treatment for 48 hours. HVHDF will be performed via indwelling central venous catheter. The blood flow will be 180-240 ml/min, and ultrafiltration rate will be 70 ml/kg/h during HVHF. The substitute fluid will be infused with pre-dilution. Heparin will be used for anti-coagulation, whose initial dose will be 15-25 U/kg, and maintenance dose is 5-15 U/kg/h. aPTT time maintained between 60-80 second and will be checked every 12 hours.
Patients will receive the usual care
Time frame: 24 hours after start of HVHDF
Change in arterial oxygen pressure (PaO2) in units of millimeter mercury (mmHg)
Time frame: 0 hour, 24 hours, and 48 hours after start of HVHDF
Changes in the ratio of arterial oxygen pressure to the fraction of inspired oxygen (PaO2/ FiO2 ratio)
Time frame: 0 hour, 24 hours, and 48 hours after start of HVHDF
Changes in compliance (ml/cmH2O)
Time frame: 28 days
Days until weaning the patient from mechanical ventilation (MV)
Time frame: 0 hour, 24 hours, and 48 hours after start of HVHDF
Changes in Interleukin-6 (ng/dL)
Assiut University
Other
Effect of High Volume Hemodiafiltration on Lung Oxygenation, Lung Mechanics and Biomarkers in Mechanically Ventilated Patients With Severe Sepsis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05713188
Haemofiltration
Nijmegen, Gelderland, Netherlands
View Trial DetailsNCT06433076
Lung Diseases, Lung Mechanics
Bangkok, Thailand
View Trial DetailsNCT03359369
Nonseptic Patients, Septic Patients
Banī Suwayf, Egypt
View Trial DetailsNCT01584999
Septic Patients
Torrette Di Ancona, Ancona, Italy
View Trial Details